A NOVEL CONJUGATE OF GRANULOCYTE COLONY-STIMULATING FACTOR(G-CSF) WITH POLYETHYLENE GLYCOL

The present invention relates to pharmaceuticals and medicine, namely, to new physiologically active conjugates of granulocyte colony-stimulating factor (G-CSF) with the general formula (I) where: n - integers from 681 to 1 000; m - integer > 4; NaH-G-CSF - natural or recombinant polypetide, havi...

Full description

Saved in:
Bibliographic Details
Main Authors DENISOV LEV ALEXANDROVICH, RUDENKO ELENA GEORGIEVNA, MOROZOVA ELENA LEONIDOVNA, CHERNOVSKAYA TATYANA VENIAMINOVNA
Format Patent
LanguageEnglish
Korean
Published 29.04.2013
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to pharmaceuticals and medicine, namely, to new physiologically active conjugates of granulocyte colony-stimulating factor (G-CSF) with the general formula (I) where: n - integers from 681 to 1 000; m - integer > 4; NaH-G-CSF - natural or recombinant polypetide, having the activity of G-CSF. The invention is also related to medicines containing the claimed conjugate of formula (I), pharmaceutical compositions, the use of conjugate of formula (I) for drugs and medicines with granulocyte colony stimulating factor as an active ingredient, approaches to prevent and / or treat neutropenia, the container that comprises pharmaceutical composition.
Bibliography:Application Number: KR20137001860